A disciplined bottom-up investment house systematically isolating fundamental worth from market sentiment.
The InCred Healthcare Portfolio embraces a Process, Allocation, and Risk-Reward standard. It provides a disciplined structure designed to protect and compound capital by investing with a pragmatic (GARP) approach.
Strategically positioned to capitalise on long-term trends in Pharma & Healthcare with exposure to secular non-discretionary segments like Branded Generics, Hospitals, and Diagnostics.
“We invest in financial integrity, operate through rigorous scoring, and execute with valuation discipline to protect and compound capital.”
Using the EDGE Framework (Earnings power, Durability, Governance, and Equity efficiency) alongside a rigid 30-point scoring audit to exploit valuation asymmetries.
EV/EBITDA is prioritized for Pharma & Healthcare because it neutralizes distortions from differing capital structures, depreciation policies on heavy asset bases (hospitals), R&D-driven intangibles (pharma), and varying tax regimes across geographies.
Strategy growth vs Benchmark index
1-Year Return: 11.3% | 3-Year Return: 27.0%
Disclaimer: Investments in Portfolio Management Services (PMS) are subject to market risks. Past performance may or may not be sustained in the future and should not be considered a guarantee of future returns.